https://doi.org/10.1016/s0140-6736(24)00054-0
G
Gabriele Antonarelli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
768
Citations
15
h-index
22
i10-index
Gabriele Antonarelli is an academic researcher from University of Milan. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies. The author has an h-index of 15, co-authored 60 publications.
ORCID: 0000-0002-9758-3665Papers by this author
works3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
2024 · The Lancet · 72 citations
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment
2023 · Cancers · 66 citations
https://doi.org/10.3390/cancers15030767
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility
2023 · Critical Reviews in Oncology/Hematology · 20 citations
https://doi.org/10.1016/j.critrevonc.2023.104148
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
2025 · Nature Medicine · 12 citations
https://doi.org/10.1038/s41591-025-03734-3
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: PALMIRA Trial
2025 · Journal of Clinical Oncology · 10 citations
https://doi.org/10.1200/jco-24-01865
Voriconazole and Non-Melanoma Skin Cancer after Allogeneic HSCT: Results of a Prospective Dedicated Follow-up Program in 302 Patients
2016 · Blood · 7 citations
https://doi.org/10.1182/blood.v128.22.3442.3442
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat